Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These antibodies activate the immune system and enable T cells to detect and destroy ...
Verywell Health on MSN
Is kidney cancer curable? Understanding the odds
Medically reviewed by Doru Paul, MD Key Takeaways Kidney cancer in early stages is curable if found and treated before it spreads.Surgery is a common treatment for stages 1 to 3 kidney cancer and can ...
For smaller kidney tumors, doctors may recommend a partial nephrectomy. This surgery involves removing only part of your kidney. A robotic approach may reduce your recovery time and risk of ...
Vietnam Investment Review on MSN
FV doctors remove 5cm kidney tumour in time-critical robotic surgery
An Australian man in his 50s, was unexpectedly diagnosed with a kidney tumour during a routine health check-up. Following a comprehensive evaluation, Dr. Do Quang Minh, MD, MSc, head of the Urology ...
Seoul St. Mary’s Hospital, Catholic University of Korea, announced on the 16th that Professor Sunghoo Hong of the Department ...
Mount Sinai researcher recognized for innovative MRI research that could improve prediction of kidney function decline after ...
Metabolic reprogramming plays an important role in kidney cancer. We aim to investigate the causal effect of 249 metabolic biomarkers on kidney cancer from population-based data. This study extracts ...
Sportschosun, Jang Jong-ho] Professor Sung-Hoo Hong of the Department of Urology at The Catholic University of Korea, Seoul St.
Kidney volume, reflecting cumulative effects of many cysts, is an important prognostic biomarker for autosomal dominant polycystic kidney disease (ADPKD) but fails in many patients. Tracking ...
Kidney cancer is increasingly being diagnosed in younger, healthy individuals with no major risk factors such as smoking or ...
New FDA-approved combination therapy for clear cell renal cell carcinoma lowers recurrence risk after nephrectomy and offers ...
A targeted kinase inhibitor added to a two-drug immunotherapy combination slowed the progression of advanced kidney cancer in previously untreated patients, according to research led by an oncologist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results